133 related articles for article (PubMed ID: 20208395)
1. Genetic variations of the SLC22A5 gene in the Chinese and Indian populations of Singapore.
Toh DS; Yee JY; Koo SH; Murray M; Lee EJ
Drug Metab Pharmacokinet; 2010; 25(1):112-9. PubMed ID: 20208395
[TBL] [Abstract][Full Text] [Related]
2. Genetic variations of the SLC22A4 gene in Chinese and Indian populations of Singapore.
Toh DS; Koo SH; Limenta LM; Yee JY; Murray M; Lee EJ
Drug Metab Pharmacokinet; 2009; 24(5):475-81. PubMed ID: 19881261
[TBL] [Abstract][Full Text] [Related]
3. Functional genetic variation in the basal promoter of the organic cation/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5).
Tahara H; Yee SW; Urban TJ; Hesselson S; Castro RA; Kawamoto M; Stryke D; Johns SJ; Ferrin TE; Kwok PY; Giacomini KM
J Pharmacol Exp Ther; 2009 Apr; 329(1):262-71. PubMed ID: 19141711
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of pharmacogenetic variants of human organic cation/carnitine transporter 2 (hOCTN2) identified in Singaporean populations.
Toh DS; Murray M; Pern Tan K; Mulay V; Grewal T; Lee EJ; Zhou F
Biochem Pharmacol; 2011 Dec; 82(11):1692-9. PubMed ID: 21864509
[TBL] [Abstract][Full Text] [Related]
5. Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5).
Urban TJ; Gallagher RC; Brown C; Castro RA; Lagpacan LL; Brett CM; Taylor TR; Carlson EJ; Ferrin TE; Burchard EG; Packman S; Giacomini KM
Mol Pharmacol; 2006 Nov; 70(5):1602-11. PubMed ID: 16931768
[TBL] [Abstract][Full Text] [Related]
6. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein.
Ohashi R; Tamai I; Inano A; Katsura M; Sai Y; Nezu J; Tsuji A
J Pharmacol Exp Ther; 2002 Sep; 302(3):1286-94. PubMed ID: 12183691
[TBL] [Abstract][Full Text] [Related]
7. Functional regions of organic cation/carnitine transporter OCTN2 (SLC22A5): roles in carnitine recognition.
Inano A; Sai Y; Kato Y; Tamai I; Ishiguro M; Tsuji A
Drug Metab Pharmacokinet; 2004 Jun; 19(3):180-9. PubMed ID: 15499185
[TBL] [Abstract][Full Text] [Related]
8. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
9. Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency.
Koleske ML; McInnes G; Brown JEH; Thomas N; Hutchinson K; Chin MY; Koehl A; Arkin MR; Schlessinger A; Gallagher RC; Song YS; Altman RB; Giacomini KM
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2210247119. PubMed ID: 36343260
[TBL] [Abstract][Full Text] [Related]
10. Analysis of genetic mutations in Chinese patients with systemic primary carnitine deficiency.
Han L; Wang F; Wang Y; Ye J; Qiu W; Zhang H; Gao X; Gong Z; Gu X
Eur J Med Genet; 2014 Oct; 57(10):571-5. PubMed ID: 25132046
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations of the ABCC2 gene in the Chinese, Malay, and Indian populations of Singapore.
Ho WF; Koo SH; Yee JY; Lee JD
Drug Metab Pharmacokinet; 2008; 23(5):385-91. PubMed ID: 18974617
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).
Tamai I
Biopharm Drug Dispos; 2013 Jan; 34(1):29-44. PubMed ID: 22952014
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model.
Okura T; Kato S; Deguchi Y
Drug Metab Pharmacokinet; 2014; 29(1):69-74. PubMed ID: 23877104
[TBL] [Abstract][Full Text] [Related]
14. SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
Wang C; Uray IP; Mazumdar A; Mayer JA; Brown PH
Breast Cancer Res Treat; 2012 Jul; 134(1):101-15. PubMed ID: 22212555
[TBL] [Abstract][Full Text] [Related]
15. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5).
Grube M; Meyer zu Schwabedissen HE; Präger D; Haney J; Möritz KU; Meissner K; Rosskopf D; Eckel L; Böhm M; Jedlitschky G; Kroemer HK
Circulation; 2006 Feb; 113(8):1114-22. PubMed ID: 16490820
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
Wang Y; Ye J; Ganapathy V; Longo N
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2356-60. PubMed ID: 10051646
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations of the SLCO1B1 gene in the Chinese, Malay and Indian populations of Singapore.
Ho WF; Koo SH; Yee JY; Lee EJ
Drug Metab Pharmacokinet; 2008; 23(6):476-82. PubMed ID: 19122343
[TBL] [Abstract][Full Text] [Related]
18. Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.
Sugiura T; Kato Y; Kubo Y; Tsuji A
Drug Metab Pharmacokinet; 2006 Oct; 21(5):375-83. PubMed ID: 17072090
[TBL] [Abstract][Full Text] [Related]
19. Tight junction protein ZO-1 controls organic cation/carnitine transporter OCTN2 (SLC22A5) in a protein kinase C-dependent way.
Jurkiewicz D; Michalec K; Skowronek K; Nałęcz KA
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):797-805. PubMed ID: 28257821
[TBL] [Abstract][Full Text] [Related]
20. Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice.
Kato S; Kato Y; Nakamura T; Sugiura T; Kubo Y; Deguchi Y; Tsuji A
Biopharm Drug Dispos; 2009 Dec; 30(9):495-507. PubMed ID: 19821448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
